Comparison among patients ≥75 years having percutaneous coronary angioplasty using drug-eluting stents versus bare metal stents

American Journal of Cardiology

Volumn 115, Issue 9, 2015, Pages 1179-1184

  Mangiacapra, Fabio ^a,b   Ricottini, Elisabetta ^a   Di Gioia, Giuseppe ^a   Peace, Aaron ^a   Patti, Giuseppe ^a   De Bruyne, Bernard ^b   Wijns, William ^b   Barbato, Emanuele ^b   Di Sciascio, Germano ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b CARDIOVASCULAR CENTER   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; PACLITAXEL; RAPAMYCIN; ZOTAROLIMUS; ANTITHROMBOCYTIC AGENT; IMMUNOSUPPRESSIVE AGENT;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BARE METAL STENT; BLEEDING; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; DEVICE SAFETY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVASCULARIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; STENT THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT DURATION; ADVERSE EFFECTS; AGE; COMPARATIVE STUDY; DEVICES; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; STENT; TIME; TREATMENT OUTCOME; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION INHIBITORS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84927570414     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.01.557     Document Type: Article

References (30)

1. F. Colombo, G. Biondi-Zoccai, V. Infantino, P. Omede, C. Moretti, F. Sciuto, R. Siliquini, S. Chiado, G.P. Trevi, and I. Sheiban A long-term comparison of drug-eluting versus bare metal stents for the percutaneous treatment of coronary bifurcation lesions Acta Cardiol 64 2009 583 588
2. Y.H. Kim, S.W. Park, S.W. Lee, D.W. Park, S.C. Yun, C.W. Lee, M.K. Hong, H.S. Kim, J.K. Ko, J.H. Park, J.H. Lee, S.W. Choi, I.W. Seong, Y.H. Cho, N.H. Lee, J.H. Kim, K.J. Chun, and S.J. Park Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease Circulation 114 2006 2148 2153
3. J.W. Moses, M.B. Leon, J.J. Popma, P.J. Fitzgerald, D.R. Holmes, C. O'Shaughnessy, R.P. Caputo, D.J. Kereiakes, D.O. Williams, P.S. Teirstein, J.L. Jaeger, and R.E. Kuntz Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
4. E. Puymirat, F. Mangiacapra, A. Peace, F. Sharif, M. Conte, J. Bartunek, M. Vanderheyden, W. Wijns, B. de Bruyne, and E. Barbato Long-term clinical outcome in patients with small vessel disease treated with drug-eluting versus bare-metal stenting Am Heart J 162 2011 907 913
5. M. Sabate, P. Jimenez-Quevedo, D.J. Angiolillo, J.A. Gomez-Hospital, F. Alfonso, R. Hernandez-Antolin, J. Goicolea, C. Banuelos, J. Escaned, R. Moreno, C. Fernandez, F. Fernandez-Aviles, and C. Macaya Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial Circulation 112 2005 2175 2183
6. T. Palmerini, G. Biondi-Zoccai, D. Della Riva, C. Stettler, D. Sangiorgi, F. D'Ascenzo, T. Kimura, C. Briguori, M. Sabate, H.S. Kim, A. De Waha, E. Kedhi, P.C. Smits, C. Kaiser, G. Sardella, A. Marullo, A.J. Kirtane, M.B. Leon, and G.W. Stone Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis Lancet 379 2012 1393 1402
7. T. Palmerini, G. Biondi-Zoccai, D. Della Riva, A. Mariani, M. Sabate, M. Valgimigli, G. Frati, E. Kedhi, P.C. Smits, C. Kaiser, P. Genereux, S. Galatius, A.J. Kirtane, and G.W. Stone Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis J Am Coll Cardiol 62 2013 496 504
8. K. Thygesen, J.S. Alpert, A.S. Jaffe, M.L. Simoons, B.R. Chaitman, H.D. White, H.A. Katus, B. Lindahl, D.A. Morrow, P.M. Clemmensen, P. Johanson, H. Hod, R. Underwood, J.J. Bax, R.O. Bonow, F. Pinto, R.J. Gibbons, K.A. Fox, D. Atar, L.K. Newby, M. Galvani, C.W. Hamm, B.F. Uretsky, P.G. Steg, W. Wijns, J.P. Bassand, P. Menasche, J. Ravkilde, E.M. Ohman, E.M. Antman, L.C. Wallentin, P.W. Armstrong, M.L. Simoons, J.L. Januzzi, M.S. Nieminen, M. Gheorghiade, G. Filippatos, R.V. Luepker, S.P. Fortmann, W.D. Rosamond, D. Levy, D. Wood, S.C. Smith, D. Hu, J.L. Lopez-Sendon, R.M. Robertson, D. Weaver, M. Tendera, A.A. Bove, A.N. Parkhomenko, E.J. Vasilieva, and S. Mendis Third universal definition of myocardial infarction Circulation 126 2012 2020 2035
9. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, G.A. van Es, P.G. Steg, M.A. Morel, L. Mauri, P. Vranckx, E. McFadden, A. Lansky, M. Hamon, M.W. Krucoff, and P.W. Serruys Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
10. R. Mehran, S.V. Rao, D.L. Bhatt, C.M. Gibson, A. Caixeta, J. Eikelboom, S. Kaul, S.D. Wiviott, V. Menon, E. Nikolsky, V. Serebruany, M. Valgimigli, P. Vranckx, D. Taggart, J.F. Sabik, D.E. Cutlip, M.W. Krucoff, E.M. Ohman, P.G. Steg, and H. White Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium Circulation 123 2011 2736 2747
11. K.P. Alexander, L.K. Newby, C.P. Cannon, P.W. Armstrong, W.B. Gibler, M.W. Rich, F. Van de Werf, H.D. White, W.D. Weaver, M.D. Naylor, J.M. Gore, H.M. Krumholz, and E.M. Ohman Acute coronary care in the elderly, part I: non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology Circulation 115 2007 2549 2569
12. W.B. Batchelor, K.J. Anstrom, L.H. Muhlbaier, R. Grosswald, W.S. Weintraub, W.W. O'Neill, and E.D. Peterson Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians. National Cardiovascular Network Collaboration J Am Coll Cardiol 36 2000 723 730
13. Y. Gerber, C.S. Rihal, T.M. Sundt, J.M. Killian, S.A. Weston, T.M. Therneau, and V.L. Roger Coronary revascularization in the community. A population-based study, 1990 to 2004 J Am Coll Cardiol 50 2007 1223 1229
14. M.P. Thomas, M. Moscucci, D.E. Smith, H. Aronow, D. Share, P. Kraft, and H.S. Gurm Outcome of contemporary percutaneous coronary intervention in the elderly and the very elderly: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium Clin Cardiol 34 2011 549 554
15. S. Windecker, P. Kolh, F. Alfonso, J.P. Collet, J. Cremer, V. Falk, G. Filippatos, C. Hamm, S.J. Head, P. Juni, A.P. Kappetein, A. Kastrati, J. Knuuti, U. Landmesser, G. Laufer, F.J. Neumann, D.J. Richter, P. Schauerte, M. Sousa Uva, G.G. Stefanini, D.P. Taggart, L. Torracca, M. Valgimigli, W. Wijns, and A. Witkowski 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur Heart J 35 2014 2541 2619
16. K.P. Alexander, M.T. Roe, A.Y. Chen, B.L. Lytle, C.V.J. Pollack, J.M. Foody, W.E. Boden, S.C.J. Smith, W.B. Gibler, E.M. Ohman, and E.D. Peterson Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative J Am Coll Cardiol 46 2005 1479 1487
17. C. Johnman, K.G. Oldroyd, D.F. Mackay, R. Slack, A.C. Pell, A.D. Flapan, K.P. Jennings, H. Eteiba, J. Irving, and J.P. Pell Percutaneous coronary intervention in the elderly: changes in case-mix and periprocedural outcomes in 31,758 patients treated between 2000 and 2007 Circ Cardiovasc Interv 3 2010 341 345
18. A.W. Schoenenberger, D. Radovanovic, J.C. Stauffer, S. Windecker, P. Urban, F.R. Eberli, A.E. Stuck, F. Gutzwiller, and P. Erne Age-related differences in the use of guideline-recommended medical and interventional therapies for acute coronary syndromes: a cohort study J Am Geriatr Soc 56 2008 510 516
19. J. Belardi, G. Manoharan, M. Albertal, P. Widimsky, F.J. Neumann, S. Silber, M.B. Leon, and S. Saito The influence of age on clinical outcomes in patients treated with the resolute zotarolimus-eluting stent Catheter Cardiovasc Interv 2013 [Epub ahead of print]
20. J.R.J. Costa, A. Sousa, A.C. Moreira, R.A. Costa, G. Maldonado, M.N. Cano, E.T. Egito, E.R. Romano, M. Barbosa, R. Pavanello, C. Jardim, A. Cury, O. Berwanger, and J.E. Sousa Drug-eluting stents in the elderly: long-term (> one year) clinical outcomes of octogenarians in the DESIRE (Drug-Eluting Stents in the REal world) registry J Invasive Cardiol 20 2008 404 410
21. M.S. Marcolino, C. Simsek, S.P. de Boer, R.T. van Domburg, R.J. van Geuns, P. de Jaegere, K.M. Akkerhuis, J. Daemen, P.W. Serruys, and E. Boersma Short- and long-term outcomes in octogenarians undergoing percutaneous coronary intervention with stenting EuroIntervention 8 2012 920 928
22. K.R. Bainey, C.M. Norris, M.M. Graham, W.A. Ghali, M.L. Knudtson, and R.C. Welsh Clinical in-stent restenosis with bare metal stents: is it truly a benign phenomenon? Int J Cardiol 128 2008 378 382
23. J.A. Spertus, R. Kettelkamp, C. Vance, C. Decker, P.G. Jones, J.S. Rumsfeld, J.C. Messenger, S. Khanal, E.D. Peterson, R.G. Bach, H.M. Krumholz, and D.J. Cohen Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry Circulation 113 2006 2803 2809
24. G. Ndrepepa, F.J. Neumann, S. Schulz, M. Fusaro, S. Cassese, R.A. Byrne, G. Richardt, K.L. Laugwitz, and A. Kastrati Incidence and prognostic value of bleeding after percutaneous coronary intervention in patients older than 75 years of age Catheter Cardiovasc Interv 83 2014 182 189
25. A. Colombo, A. Chieffo, A. Frasheri, R. Garbo, M. Masotti-Centol, N. Salvatella, J.F. Oteo Dominguez, L. Steffanon, G. Tarantini, P. Presbitero, A. Menozzi, E. Pucci, J. Mauri, B.M. Cesana, G. Giustino, and G. Sardella Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial J Am Coll Cardiol 64 2014 2086 2097
26. M. Gilard, P. Barragan, A.A. Noryani, H.A. Noor, T. Majwal, T. Hovasse, P. Castellant, M. Schneeberger, L. Maillard, E.E. Bressolette, J. Wojcik, N. Delarche, D. Blanchard, B. Jouve, O. Ormezzano, F. Paganelli, G. Levy, J. Sainsous, D. Carrie, A. Furber, J. Berland, O. Darremont, H. Le Breton, A. Lyuycx-Bore, A. Gommeaux, C. Cassat, A. Kermarrec, P. Cazaux, P. Druelles, R. Dauphin, J. Armengaud, P. Dupouy, D. Champagnac, P. Ohlmann, K.K. Endresen, H. Benamer, R.G. Kiss, I. Ungi, J.J. Boschat, and M.C. Morice Six-month versus 24-month dual antiplatelet therapy after implantation of drug eluting stents in patients non-resistant to aspirin: ITALIC, a randomized multicenter trial J Am Coll Cardiol 65 2015 777 786
27. J.M. Cheng, Y. Onuma, N. Piazza, R.J. Nuis, R.T. Van Domburg, and P.W. Serruys Comparison of five-year outcome of octogenarians undergoing percutaneous coronary intervention with drug-eluting versus bare-metal stents (from the RESEARCH and T-SEARCH Registries) Am J Cardiol 106 2010 1376 1381
28. T.Y. Wang, F.A. Masoudi, J.C. Messenger, K.A. Shunk, A. Boyle, J.M. Brennan, H.V. Anderson, K.J. Anstrom, D. Dai, E.D. Peterson, P.S. Douglas, and J.S. Rumsfeld Percutaneous coronary intervention and drug-eluting stent use among patients ≥85 years of age in the United States J Am Coll Cardiol 59 2012 105 112
29. E. Puymirat, F. Mangiacapra, A. Peace, Y. Ntarladimas, M. Conte, J. Bartunek, M. Vanderheyden, W. Wijns, B. de Bruyne, and E. Barbato Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease Arch Cardiovasc Dis 106 2013 554 561
30. A. de Belder, J.M. de la Torre Hernandez, R. Lopez-Palop, P. O'Kane, F. Hernandez Hernandez, J. Strange, F. Gimeno, J. Cotton, J.F. Diaz Fernandez, P. Carrillo Saez, M. Thomas, E. Pinar, N. Curzen, J.A. Baz, N. Cooter, I. Lozano, N. Skipper, D. Robinson, and D. Hildick-Smith A prospective randomized trial of everolimus-eluting stents versus bare-metal stents in octogenarians: the XIMA Trial (Xience or Vision Stents for the Management of Angina in the Elderly) J Am Coll Cardiol 63 2014 1371 1375